The AI Memory Play That's Already Moving

Every AI memory chip must pass through this checkpoint, and one firm owns it.

September 16, 2026

The HBM build-out has a bottleneck few discuss. Not the fabs. The testing gear. A roughly $8 to $9 billion Bay Area equipment maker gets paid on every HBM stack that rolls off a Micron or SK Hynix line, and shares have run from under $28 to over $100 in the past year while you probably still can't name the ticker.

Elite Picks (Sponsored)

This report focuses on a narrow group of stocks identified through a detailed screening process.

Analysts apply a combination of metrics to narrow down potential opportunities.

Past selections have shown strong momentum, but no outcomes are guaranteed.

The newest edition is now open for access.

Get the report now.

*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.

*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.

Hyperscaler capex keeps expanding into 2027. HBM allocation is spoken for well past next year. And the company that inspects every one of those memory stacks before it heads into advanced packaging? Trading on the NYSE under a ticker most of your friends have never opened.

FormFactor (NASDAQ: FORM) builds the probe cards and test systems that sit between the tester and the chip, and its high-bandwidth memory probe cards are qualified at the leading memory makers, so essentially every HBM stack gets contacted by its hardware before it moves into advanced packaging.

Management has pointed to a richer HBM mix inside the foundry and systems segments as the driver of the next leg of growth, with legacy DRAM probe cards still the soft spot. Track whether that HBM mix keeps stepping higher in the next print before you size a position.

Shares have already re-rated hard off the lows. The stock trades around $101.69 with a market cap near $7.9 billion, up from a 52-week low of $30.20. Your real question now is whether HBM probe card orders and the foundry recovery justify where the multiple goes from here.

Action: Accumulate FORM into the Q3 earnings print in late October and the HBM mix update that comes with it.

What Just Happened

FormFactor's last quarter showed the HBM mix inside its foundry and systems segments stepping higher, even as legacy DRAM probe cards stayed sluggish.

That matters to you. HBM probe cards carry structurally better pricing than commodity DRAM probes, and every incremental point of HBM mix drops straight through to gross margin.

The signal to focus on: management guided next quarter above the Street on stronger HBM demand from a leading memory customer. This isn't a one-quarter blip. HBM3E is ramping into HBM4 through 2027, and every generation needs a new probe card platform, requalified from scratch. Razor and blades, in the truest sense, and you're early.

Standout Picks Now (Sponsored)

Every market cycle produces a handful of companies that dramatically outperform the rest.

Our latest screening has identified the 5 Stocks Set to Double — companies showing rare early-stage momentum traits.

These picks carry the same indicators that historically precede strong rallies.

Past reports highlighted stocks that surged +175%, +498%, and +673%.

Get the Free 5 Stocks Set to Double Report.

*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.

*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.

Apple's last breakout product category was the Watch in 2015. Does it need another one?

Login or Subscribe to participate in polls.

What the Business Actually Does

Strip the jargon and FormFactor sells the interface between the tester and the chip. When a fab wants to know whether a wafer works, it needs a probe card: a custom-machined assembly with thousands of tiny needles arranged to contact every pad on every die.

FormFactor designs and manufactures these for both your foundry (logic) and DRAM/HBM customers.

They also run one of the industry's largest independent metrology and inspection franchises, sitting inside advanced logic fabs, high-bandwidth memory lines, and leading packaging houses worldwide.

That is the moat. You want a supplier that touches the wafer at the earliest characterization step, because that is how the production process control slots get won when a node ramps to volume.

Where scarcity moves (Sponsored)

While most Americans have been distracted by the tariffs, UFO memes, and the war in Iran, Trump has been quietly assembling the most ambitious monetary reset in half a century. 

Channeling more than $3 trillion in public and private capital toward a single strategic objective.

And this is where scarcity is migrating.

Why the Market Cares Again

HBM is now a shortage market. Capacity is booked through 2027 and Micron just guided HBM revenue to grow multiple-fold next year.

Every incremental HBM stack means new probe card demand at premium ASPs, and FormFactor is one of two credible suppliers globally, giving you direct exposure.

Advanced packaging is opening a second lane. Chiplet architectures and 3D packaging (CoWoS, hybrid bonding) need entirely new probe methodologies. FormFactor's advanced probing platform is already qualified at TSMC for these workflows, giving you a second growth vector on top of HBM.

Foundry recovery is coming, whether you believe the timing or not. Logic probe cards have been in a two-year downturn as leading-edge foundries digested capacity.

But TSMC's 2nm ramp starts hitting probe card orders in the first half of 2027, and orders lead the revenue by two to three quarters. You want to own the shares before the visibility arrives, not after.

Action: Start scaling in ahead of Q3. Watch Micron's HBM commentary as a real-time demand read for FORM.

What the Financials Are Signaling

Gross margin has room to expand. The company runs at a low-to-mid 40s gross margin but management has publicly targeted 47%+ as HBM mix rises and factory utilization improves.

Every 100 basis points of margin expansion is meaningful on this revenue base. That's the earnings lever the model isn't fully crediting yet.

The balance sheet is clean. FormFactor carries a net cash position with minimal debt. That gives you downside protection through any cyclical air pocket, plus dry powder for a tuck-in acquisition in advanced probing. No capital raise diluting your entry.

Free cash flow is understating the story. Reported FCF has been depressed by capex tied to a major new facility at Farmers Branch, with $140 to $170 million in 2026 capex guiding that build-out for HBM4 tooling.

Once that capex normalizes in 2027, FCF conversion snaps back and you see the real earning power of the business.

The Valuation Problem No One Should Ignore

Premium to trough, discount to peers. FORM trades above trough multiples but at a real discount to Onto (NYSE: ONTO), Camtek (NASDAQ: CAMT), and Nova (NASDAQ: NVMI), all of which have re-rated on the same HBM and advanced packaging thesis.

The bear case says FormFactor deserves the discount because its foundry business is more cyclical. The bull case says that's exactly the mispricing you want.

The bear case isn't crazy. If HBM oversupply hits in 2027 (and memory always overshoots), probe card demand normalizes fast. You're paying a growth multiple for a business that has burned holders before. Be honest about that risk when you size the position.

Bear Case

Customer concentration. A handful of memory and foundry customers drive most of the revenue. If one cuts capex or delays a node, your quarter slips.

HBM competition. Rival probe card makers, particularly in Korea and Japan, are chasing the same HBM sockets. Losing a socket at SK Hynix or Samsung would be a real setback.

Cyclical whiplash. Semi test is a shorter-cycle business than semi cap equipment. If the market catches a memory glut scare in 2027, FORM trades down first and asks questions later.

Capex overrun risk. The Farmers Branch build-out is a big bet on HBM4 tooling demand materializing on schedule. If it slips, near-term FCF looks worse before it looks better.

Action: Hedge with broader semi cap exposure like Onto Innovation (ONTO), which used its September 9, 2026 appearance at Citi's Global TMT Conference to reiterate about 40% growth in 2026, nearly double the pace of peers in wafer fabrication equipment, on a backlog above $1.1 billion, or a semi ETF to smooth out single-name cyclicality. If you're aggressive and comfortable with volatility, size FORM heavier and add on dips.

What Needs to Happen Next

Q3 earnings (late October). The most important read for you is HBM revenue as a percent of total. If it steps up sequentially and management raises the mid-term margin target, the stock re-rates. If HBM is flat, your thesis pushes out a quarter.

TSMC's 2nm probe card orders. Watch for management commentary on advanced foundry order momentum on the call. Any hint that 2nm probe cards are already booking is a leading indicator worth another turn of the multiple.

Micron's fiscal Q4 print. Micron reports and HBM commentary from them reads directly through to FORM's demand. Micron is a top-three customer.

How I'd Frame a Position

Start scaling now. Take a starter position in the range ahead of the next quarterly print. Don't wait for the report if you like the setup.

HBM and advanced packaging commentary from Micron and the broader memory complex has been strong enough that a beat on test tool demand wouldn't shock.

Add on any further pullback. The shares have been volatile around every memory headline, and if a flush extends back toward the recent base, that's your chance to double up. Semi test names often overshoot to the downside on any guidance wobble even when the underlying trajectory is intact.

If you already own it. Hold through the cycle. The multi-year HBM and AI compute test story, reinforced by the new UltraFLEXplus instruments launched this month and the Tokyo Electron known-good-die partnership, matters more than any single quarter, and trimming a compounder in the middle of its re-rate is the mistake you'll regret.

The Picks-and-Shovels Play on HBM

FormFactor is the picks-and-shovels play on HBM that the market keeps under-owning because the business is easy to overlook next to the marquee AI names.

Every HBM stack, every 2nm wafer, every chiplet package flows through probe testing, and FORM sits right at the toll booth. Buy the Q3 earnings setup, size it like the cyclical it is, and let the multi-year memory and packaging cycle do the work.

Setup Scorecard

Entry Zone: $95–$104
Target: $125
Stop Loss: Reassess below $88

Catalyst Timeline: Q3 earnings in late October; Micron fiscal Q4 print; TSMC 2nm order commentary

Confidence Level: Medium-High. The HBM ramp is real and multi-year, but the stock is cyclical, so size accordingly.

That's our coverage for today; thanks for reading! Reply to this email with feedback or any tech stocks you want me to check out.

Best Regards,
—Noah Zelvis
Tech Stock Insider